Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

    Home > Events > Veristat to attend bio europe spring 2017 event

    1 min read

    Veristat to Attend Bio Europe Spring 2017 Event

    Join Veristat and nearly 2,500 professionals from biotech, pharma, finance and life sciences industry across Europe’s most innovative biopharma clusters at the  Bio Europe Spring 2017 event.

    PPT-Icon_Calendar_March-2017.jpg

     

    March 20–22, 2017

    CCIB Convention Centre,  Barcelona, Spain

     

     

    Why Consider Working with Veristat?

    Veristat really enjoys helping small firms grow as they advance thier single product or even small pipeline of products through the clinical development and regulatory submission process.   Consider meeting us at BioEurope Spring to discuss your current programs and tell us about the current challenges you are facing.     

    Learn how we've helped a current client as they grew not only thier company, but took thier product through the development process:

    A Case Study |  How Veristat Helps Growing Biotech Firms

    A current client started working with Veristat over 6 years ago as a small venture funded biotech firm.   Our initial engagement began with strategic consulting for their clinical development program and representation at numerous agency meetings (EMA & FDA), which has evolved over time to running over 15 studies.   We helped them as they grew from a 4 person to a 300 person firm.  Today, we remain a preferred provider and are working on thier submission for the original product that we helped them with.

    Schedule A Meeting      

    To meet up with Veristat at this event, connect with us through the conference partnering system or fill out the form on the right side of this page.

    We look forward to meeting you in Barcelona!

    Share This Event:

       

    11 min read

    Monthly FDA Guidance and Regulatory News Review - September 2026

    This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...

    8 min read

    Monthly FDA Guidance and Regulatory News Review - August 2026

    This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...